PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
45.60%
Positive revenue growth while JHX is negative. John Neff might see a notable competitive edge here.
402.71%
Positive gross profit growth while JHX is negative. John Neff would see a clear operational edge over the competitor.
3233.53%
EBIT growth above 1.5x JHX's 73.60%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
3233.53%
Operating income growth above 1.5x JHX's 73.60%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
228.01%
Positive net income growth while JHX is negative. John Neff might see a big relative performance advantage.
346.15%
Positive EPS growth while JHX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
338.46%
Positive diluted EPS growth while JHX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-28.12%
Share reduction while JHX is at 0.09%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-27.47%
Reduced diluted shares while JHX is at 0.11%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
527.53%
Positive 10Y revenue/share CAGR while JHX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
166.09%
Positive 5Y CAGR while JHX is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
2359.29%
Positive 3Y CAGR while JHX is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
729.57%
Net income/share CAGR above 1.5x JHX's 232.53% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
152.48%
5Y net income/share CAGR at 50-75% of JHX's 232.53%. Martin Whitman might see a shortfall in operational efficiency or brand power.
41.63%
Below 50% of JHX's 232.53%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while JHX invests at 11.52%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.